Baxter International | BAX - Le Coût Des Ventes





Le Coût Des Ventes Changement Date
Abbott USD 5.94B 642M 2026-06
AngioDynamics USD 37.29M 786K 2025-09
Artivion USD 42.85M 3.86M 2025-12
AtriCure USD 34.98M 3.04M 2026-06
Baxter International USD 1.93B 118M 2026-06
Becton, Dickinson and Co. USD 2.67B 108M 2026-06
Boston Scientific USD 1.86B 29M 2026-06
Cooper Companies USD 401.3M 7.5M 2026-06
Dexcom USD 478.4M 36.8M 2026-06
Edwards Lifesciences USD 392.4M 29.8M 2026-06
Fresenius EUR 4.4B 111M 2026-06
Globus Medical USD 271M 7.41M 2026-06
Halozyme Therapeutics USD 108.68M 67K 2026-06
ICU Medical USD 316.63M 7.37M 2026-06
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 239.1M 6.4M 2026-06
Integra LifeSciences USD 188.86M 10.15M 2026-06
Intuitive Surgical USD 931.9M 8.4M 2026-06
J&J USD 8B 67M 2026-06
Laboratory Of America USD 2.7B 97.8M 2026-06
Medtronic USD 3.83B 26M 2026-06
Merit Medical Systems USD 203.68M 6.6M 2026-06
Quest Diagnostics USD 2.05B 64M 2026-06
Smith & Nephew USD 901M 31M 2026-06
Stryker USD 2.26B 106M 2026-06
Tandem Diabetes Care USD 109.78M 653K 2026-06
Teleflex USD 238.62M 2.21M 2026-06
Terumo JPY 133.27B 18.03B 2026-06
Zimmer Biomet Holdings USD 815.9M 77.6M 2026-06